HB0045 Drug Product Clinical Trials

0 actively recruiting trials

Also known as: fixed dose combination of two antibodies targeting two different epitopes (N-terminal and catalytic site) of CD73

No trials match the selected filters.

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.